Annual Accounts Receivable
N/A
December 31, 2023
Summary
- ENVB annual accounts receivable is not available.
Performance
ENVB Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- ENVB quarterly accounts receivable is not available.
Performance
ENVB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ENVB Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ENVB Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Enveric Biosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $7.56 M(+3.7%) |
| Jun 2020 | - | $7.29 M(-10.0%) |
| Mar 2020 | - | $8.10 M(+26.9%) |
| Dec 2019 | $6.38 M(-18.9%) | $6.38 M(-16.1%) |
| Sep 2019 | - | $7.61 M(-10.9%) |
| Jun 2019 | - | $8.54 M(-4.0%) |
| Mar 2019 | - | $8.90 M(+13.1%) |
| Dec 2018 | $7.87 M(-10.9%) | $7.87 M(+0.5%) |
| Sep 2018 | - | $7.83 M(-1.4%) |
| Jun 2018 | - | $7.94 M(-6.2%) |
| Mar 2018 | - | $8.46 M(-4.3%) |
| Dec 2017 | $8.84 M(+9.7%) | $8.84 M(-3.6%) |
| Sep 2017 | - | $9.17 M(+5.1%) |
| Jun 2017 | - | $8.72 M(-9.1%) |
| Mar 2017 | - | $9.59 M(+19.0%) |
| Dec 2016 | $8.06 M(+65.4%) | $8.06 M(+4.3%) |
| Sep 2016 | - | $7.72 M(+86.9%) |
| Jun 2016 | - | $4.13 M(-16.1%) |
| Mar 2016 | - | $4.93 M(-45.0%) |
| Dec 2015 | $4.87 M(+6413.5%) | - |
| Sep 2015 | - | $8.96 M(+91.2%) |
| Jun 2015 | - | $4.68 M(>+9900.0%) |
| Jun 2007 | - | $35.10 K(-23.0%) |
| Mar 2007 | - | $45.60 K(-39.0%) |
| Dec 2006 | $74.80 K | $74.80 K(+7.5%) |
| Sep 2006 | - | $69.60 K(-17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $84.00 K(-11.9%) |
| Mar 2006 | - | $95.40 K(-38.5%) |
| Dec 2005 | $155.20 K(-52.3%) | $155.20 K(-17.2%) |
| Sep 2005 | - | $187.40 K(+3.9%) |
| Jun 2005 | - | $180.40 K(+5.7%) |
| Mar 2005 | - | $170.60 K(-47.6%) |
| Dec 2004 | $325.70 K(-5.7%) | $325.70 K(+56.6%) |
| Sep 2004 | - | $208.00 K(-39.8%) |
| Jun 2004 | - | $345.30 K(+89.2%) |
| Mar 2004 | - | $182.50 K(-47.2%) |
| Dec 2003 | $345.40 K(-30.8%) | $345.40 K(+5.7%) |
| Sep 2003 | - | $326.90 K(+32.8%) |
| Jun 2003 | - | $246.20 K(-28.7%) |
| Mar 2003 | - | $345.50 K(-30.8%) |
| Dec 2002 | $499.00 K(+12.7%) | $499.00 K(+3.1%) |
| Sep 2002 | - | $484.00 K(+5.8%) |
| Jun 2002 | - | $457.40 K(+0.1%) |
| Mar 2002 | - | $456.80 K(+3.2%) |
| Dec 2001 | $442.60 K(-35.6%) | $442.60 K(-9.5%) |
| Sep 2001 | - | $488.90 K(-7.8%) |
| Jun 2001 | - | $530.00 K(+18.0%) |
| Mar 2001 | - | $449.10 K(+233.7%) |
| Dec 1999 | $687.60 K(+410.8%) | - |
| Dec 1998 | $134.60 K(-85.2%) | $134.60 K(-85.2%) |
| Dec 1997 | $911.50 K(+11.0%) | $911.50 K(+11.0%) |
| Dec 1996 | $820.90 K | $820.90 K |
FAQ
- What is the all time high annual accounts receivable for Enveric Biosciences?
- What is the all time high quarterly accounts receivable for Enveric Biosciences?
What is the all time high annual accounts receivable for Enveric Biosciences?
Enveric Biosciences all-time high annual accounts receivable is $8.84 M
What is the all time high quarterly accounts receivable for Enveric Biosciences?
Enveric Biosciences all-time high quarterly accounts receivable is $9.59 M